Colistin Versus Ceftazidime-Avibactam in the Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae

BACKGROUND: The efficacy of ceftazidime-avibactam—a cephalosporin–β-lactamase inhibitor combination with in vitro activity against Klebsiella pneumoniae carbapenemase–producing carbapenem-resistant Enterobacteriaceae (CRE)—compared with colistin remains unknown. METHODS: Patients initially treated w...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Clin Infect Dis
Hlavní autoři: van Duin, David, Lok, Judith J, Earley, Michelle, Cober, Eric, Richter, Sandra S, Perez, Federico, Salata, Robert A, Kalayjian, Robert C, Watkins, Richard R, Doi, Yohei, Kaye, Keith S, Fowler, Vance G, Paterson, David L, Bonomo, Robert A, Evans, Scott
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2018
Témata:
Articles and Commentaries
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5850032/
https://ncbi.nlm.nih.gov/pubmed/29020404
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cix783
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky